Tag Archives: MRI

Nephrogenic Systemic Fibrosis and the FDA’s Warnings

There is an article (Change in Use of Gadolinium-Enhanced Magnetic Resonance Studies in Kidney Disease Patients After US Food and Drug Administration Warnings: A Cross-sectional Study of Veterans Affairs Health Care System Data From 2005-2008 ) and an editorial (Nephrogenic Systemic Fibrosis and Gadolinium-Enhanced Magnetic Resonance Imaging: Does a US Food and Drug Administration Alert…

Read the full entry

More on Gadolinium and NSF

More evidence mounts supporting the causal role of gadolinium containing MRI contrast agents and nephrogenic systemic fibrosis (NSF) in patients on dialysis. Two papers in the June 2008 issue of the American Journal of Kidney Diseases examine the issue. Kallen, et all report that “Receipt of gadolinium-containing MRI contrast is associated with NSF in a…

Read the full entry